|
Volumn 313, Issue 4, 2015, Pages 359-360
|
Maximizing antiretroviral therapy in developing countries: The dual challenge of efficiency and quality
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIRETROVIRAL THERAPY;
ANTIVIRAL THERAPY;
DEVELOPING COUNTRY;
FUNDING;
HEALTH CARE COST;
HEALTH CARE QUALITY;
HEALTH CARE UTILIZATION;
HEALTH PROGRAM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCIDENCE;
MORTALITY;
NOTE;
PATIENT TRANSPORT;
RESOURCE MANAGEMENT;
SCALE UP;
SOCIOECONOMICS;
STANDARDIZATION;
VIRUS LOAD;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADULT;
DRUG COST;
ECONOMICS;
HEALTH;
HIV INFECTIONS;
OUTCOME ASSESSMENT;
PRACTICE GUIDELINE;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADULT;
ANTI-HIV AGENTS;
DEVELOPING COUNTRIES;
DRUG COSTS;
GLOBAL HEALTH;
GUIDELINE ADHERENCE;
HIV INFECTIONS;
HUMANS;
INCIDENCE;
OUTCOME ASSESSMENT (HEALTH CARE);
|
EID: 84921794166
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2014.16376 Document Type: Note |
Times cited : (10)
|
References (6)
|